An exclusive whitepaper produced for Arabian Travel Market (ATM) by Digital Tourism Think Tank (DTTT) has highlighted that only 15% of UN

The article discusses the connection between type 2 diabetes mellitus (T2DM) and neurodegenerative disorders, with a focus on the role of mitochondrial dysfunction as a potential link between these conditions. It reviews the epidemiological and molecular evidence that suggests T2DM as a risk factor for the development of Alzheimer's disease and Parkinson's disease, and highlights the importance of understanding the mitochondrial mechanisms underlying this relationship to identify new therapeutic targets.

This cross-sectional population-based study examined the relationship between statin use and anti-Alzheimer's disease (AD) drug prescription in patients over 70 years old with cardiovascular risk factors. The key findings were: 1) Patients using low-potency or hydrophilic statins had lower odds of anti-AD medication usage compared to high-potency or lipophilic statins, respectively; 2) Patients taking rosuvastatin or pitavastatin had lower odds of anti-AD medication usage than those consuming atorvastatin.